ZL-2103

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameZL-2103
Drug Alias NameZL-2103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZai Lab (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZai Lab (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A